Danilov AV, Li H, Shadman M, Rimsza L, et al. Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial. Haematologica 2025 Jul 3. doi: 10.3324/haematol.2025.288057.
PMID: 40605713